Early-stage drug candidate diminishes deficits in Parkinson’s Disease
Chemical compound reduces alpha-synuclein, cell stress.
Read MoreChemical compound reduces alpha-synuclein, cell stress.
Read MoreEfforts to understand the genetics of neurological diseases leads to a potential treatment.
Read More